Emergence of high-level resistance to glycopeptides in Enterococcus gallinarum and Enterococcus casseliflavus - PubMed (original) (raw)

Emergence of high-level resistance to glycopeptides in Enterococcus gallinarum and Enterococcus casseliflavus

S Dutka-Malen et al. Antimicrob Agents Chemother. 1994 Jul.

Abstract

Enterococcus gallinarum BM4231 and Enterococcus casseliflavus BM4232, isolated from the feces of a patient under oral therapy with vancomycin, were resistant to high levels of vancomycin (MICs of > 256 micrograms/ml) and teicoplanin (MICs of 128 and 64 micrograms/ml, respectively). This phenotype is new for these bacterial species that are naturally resistant to low levels of vancomycin and appears to be due to in vivo acquisition of plasmid pIP218 carrying the vanA gene cluster.

PubMed Disclaimer

References

    1. Biochemistry. 1991 Oct 29;30(43):10408-15 -PubMed
    1. Mol Gen Genet. 1990 Dec;224(3):364-72 -PubMed
    1. Gene. 1992 Mar 1;112(1):53-8 -PubMed
    1. Antimicrob Agents Chemother. 1992 Feb;36(2):502-4 -PubMed
    1. Lancet. 1992 Oct 31;340(8827):1105 -PubMed

MeSH terms

Substances

LinkOut - more resources